Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the sustainability of the nuclear medicine workforce in the context of the potential increase in availability of (a) radioligand therapy and (b) other nuclear medicines to treat certain cancers.

No specific assessment has been made. However, Health Education England plan to increase the number of posts in nuclear medicine by 10 each year in 2023/24 and 2024/25 through its cancer and diagnostic programme.

It is expected that all new therapeutic radioligand treatments for cancer will be appraised by the National Institute of Health and Care Excellence via its technology appraisal process.